InVivo Therapeutics competitors

InVivo Therapeutics's competitors include Diasome, ACADIA Pharmaceuticals, Semma Therapeutics, Brainstorm Cell Therapeutics and NeuralStem
Add company...
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
Diasome
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.
NeuralStem
NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
Founding Date
Founding Date
2005
Founding Date
2004
Founding Date
1993
Founding Date
2015
Founding Date
2004
Founding Date
1996
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cleveland, US HQ
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Providence, US
Locations
Hackensack, US HQ
Holon, IL
Locations
Rockville, US HQ
Employees
Employees
37
Employees
8
Employees
42515% increase
Employees
376% increase
Employees
1726% decrease
Employees
11
Valuation ($)
Valuation ($)
10.5 m
Valuation ($)
N/A
Valuation ($)
1.9 b
Valuation ($)
N/A
Valuation ($)
84.3 m
Valuation ($)
24.7 m
Facebook likes
Facebook likes
12.4 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
2.1 k
Facebook likes
1.2 k
Twitter followers
Twitter followers
1.2 k
Twitter followers
62
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
703
Twitter followers
2.2 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$124.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$16.2k (FY, 2016)
Net income
Net income
($26.7m) (FY, 2017)
Net income
N/A
Net income
($289.4m) (FY, 2017)
Net income
N/A
Net income
($5m) (FY, 2017)
Net income
($21.1m) (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 30m (12 months ago)
Latest funding round
N/A
Latest funding round
$ 114m (7 months ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 75.2m
Total funding raised
$ 42.9m
Total funding raised
N/A
Total funding raised
$ 163m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Diasome
HQ
Cleveland, US
Employees
8

Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.

View company
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
425↑ 15% increase

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

View company
Semma Therapeutics
HQ
Cambridge, US
Employees
37↑ 6% increase

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

View company
Brainstorm Cell Therapeutics
HQ
Hackensack, US
Employees
17↓ 26% decrease

BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.

View company